Introduction: A diagnosis of transient ischemic attack (TIA) must be followed by prompt investigation and rapid initiation of measures to prevent stroke. Prior studies evaluating the risk of stroke after TIA were conducted in the emergency room or clinic settings. Experience of patients admitted to the hospital after a TIA is not well known. We sought to assess the early risk of ischemic stroke after inpatient hospitalization for TIA. Methods: We used the 2010–2015 Nationwide Readmissions Database to identify all hospitalizations with the primary discharge diagnosis of TIA and investigated the incidence of ischemic stroke readmissions within 90 days of discharge from the index hospitalization. Results: Of 639,569 index TIA admissions discharged alive (mean ± SD age 70.4 ± 14.4 years, 58.7% female), 9,131 (1.4%) were readmitted due to ischemic stroke within 90 days. Male sex, head/neck vessel atherosclerosis, hypertension, diabetes, atrial flutter/fibrillation, previous history of TIA/stroke, illicit drug use, and higher Charlson Comorbidity Index score were independently associated with readmissions due to ischemic stroke. Ischemic stroke readmissions were associated with excess mortality, discharge disposition other than to home, and elevated cost. Conclusions: Patients hospitalized for TIA have a lower risk of ischemic stroke compared to that reported in the studies based on the emergency room and/or outpatient clinic evaluation. Among these patients, those with cardiovascular comorbidities remain at a higher risk of readmission due to ischemic stroke despite undergoing an inpatient evaluation and should therefore be the target for future preventive strategies.

1.
Lichtman
JH
,
Jones
SB
,
Watanabe
E
,
Allen
NB
,
Wang
Y
,
Howard
VJ
, et al
Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack
.
Stroke
.
2009
;
40
(
6
):
2116
22
. .
2.
Wu
CM
,
McLaughlin
K
,
Lorenzetti
DL
,
Hill
MD
,
Manns
BJ
,
Ghali
WA
.
Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis
.
Arch Intern Med
.
2007
;
167
(
22
):
2417
22
. .
3.
Hill
MD
,
Yiannakoulias
N
,
Jeerakathil
T
,
Tu
JV
,
Svenson
LW
,
Schopflocher
DP
.
The high risk of stroke immediately after transient ischemic attack: a population-based study
.
Neurology
.
2004
;
62
(
11
):
2015
20
. .
4.
Johnston
SC
,
Gress
DR
,
Browner
WS
,
Sidney
S
.
Short-term prognosis after emergency department diagnosis of TIA
.
JAMA
.
2000
;
284
(
22
):
2901
6
. .
5.
Rothwell
PM
,
Giles
MF
,
Chandratheva
A
,
Marquardt
L
,
Geraghty
O
,
Redgrave
JN
, et al
Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison
.
Lancet
.
2007
;
370
(
9596
):
1432
42
. .
6.
Easton
JD
,
Saver
JL
,
Albers
GW
,
Alberts
MJ
,
Chaturvedi
S
,
Feldmann
E
, et al
Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American heart association/American stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease. The american academy of neurology affirms the value of this statement as an educational tool for neurologists
.
Stroke
.
2009
;
40
(
6
):
2276
93
. .
7.
Johnston
SC
,
Rothwell
PM
,
Nguyen-Huynh
MN
,
Giles
MF
,
Elkins
JS
,
Bernstein
AL
, et al
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack
.
Lancet
.
2007
;
369
(
9558
):
283
92
. .
8.
Al-Khaled
M
,
Eggers
J
.
Early hospitalization of patients with TIA: a prospective, population-based study
.
J Stroke Cerebrovasc Dis
.
2014
;
23
(
1
):
99
105
. .
9.
Cosker
K
,
Samson
S
,
Fagot-Campagna
A
,
Woimant
F
,
Tuppin
P
.
First hospitalization for transient ischemic attack in France: characteristics, treatments and 3-year outcomes
.
Rev Neurol
.
2016
;
172
(
2
):
152
9
. .
10.
Khanevski
AN
,
Bjerkreim
AT
,
Novotny
V
,
Naess
H
,
Thomassen
L
,
Logallo
N
, et al
Thirty-day recurrence after ischemic stroke or TIA
.
Brain Behav
.
2018
;
8
(
10
):
e01108
. .
11.
Vigen
T
,
Thommessen
B
,
Rønning
OM
.
Stroke risk is low after urgently treated transient ischemic attack
.
J Stroke Cerebrovasc Dis
.
2018
;
27
(
2
):
291
5
. .
12.
von Weitzel-Mudersbach
P
,
Johnsen
SP
,
Andersen
G
.
Low risk of vascular events following urgent treatment of transient ischaemic attack: the Aarhus TIA study
.
Eur J Neurol
.
2011
;
18
(
11
):
1285
90
. .
13.
NRD Overview
.
Healthcare cost and utilization project (HCUP)
.
Rockville, MD, USA
:
Agency for Healthcare Research and Quality
;
2019 Dec
.
Available from: www.hcup-us.ahrq.gov/nrdoverview.jsp. [updated 2019 Dec]
.
14.
Calvet
D
,
Touzé
E
,
Oppenheim
C
,
Turc
G
,
Meder
JF
,
Mas
JL
.
DWI lesions and TIA etiology improve the prediction of stroke after TIA
.
Stroke
.
2009
;
40
(
1
):
187
92
. .
15.
O’Brien
EC
,
Zhao
X
,
Fonarow
GC
,
Schulte
PJ
,
Dai
D
,
Smith
EE
, et al
Quality of care and ischemic stroke risk after hospitalization for transient ischemic attack: findings from get with the guidelines-stroke
.
Circ Cardiovasc Qual Outcomes
.
2015
;
8
(
6 Suppl 3
):
S117
24
.
16.
Amarenco
P
,
Bogousslavsky
J
,
Callahan
A
,
Goldstein
LB
,
Hennerici
M
,
Rudolph
AE
, et al
High-dose atorvastatin after stroke or transient ischemic attack
.
N Engl J Med
.
2006
;
355
(
6
):
549
59
.
17.
Wang
Y
,
Wang
Y
,
Zhao
X
,
Liu
L
,
Wang
D
,
Wang
C
, et al
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack
.
N Engl J Med
.
2013
;
369
(
1
):
11
9
. .
18.
Wardlaw
JM
,
Brazzelli
M
,
Chappell
FM
,
Miranda
H
,
Shuler
K
,
Sandercock
PA
, et al
ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged
.
Neurology
.
2015
;
85
(
4
):
373
80
. .
19.
Amarenco
P
,
Labreuche
J
,
Lavallée
PC
.
Patients with transient ischemic attack with ABCD2 < 4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2 ≥ 4
.
Stroke
.
2012
;
43
(
3
):
863
5
. .
20.
Lavallee
PC
,
Meseguer
E
,
Abboud
H
,
Cabrejo
L
,
Olivot
JM
,
Simon
O
, et al
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects
.
Lancet Neurol
.
2007
;
6
(
11
):
953
60
.
21.
Edlow
JA
,
Kim
S
,
Pelletier
AJ
,
Camargo
CA
 Jr
.
National study on emergency department visits for transient ischemic attack, 1992–2001
.
Acad Emerg Med
.
2006
;
13
(
6
):
666
72
. .
22.
Gladstone
DJ
,
Kapral
MK
,
Fang
J
,
Laupacis
A
,
Tu
JV
.
Management and outcomes of transient ischemic attacks in Ontario
.
CMAJ
.
2004
;
170
(
7
):
1099
104
. .
23.
Kernan
WN
,
Viscoli
CM
,
Brass
LM
,
Makuch
RW
,
Sarrel
PM
,
Roberts
RS
, et al
The stroke prognosis instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke
.
Stroke
.
2000
;
31
(
2
):
456
62
. .
24.
Ois
A
,
Gomis
M
,
Rodríguez-Campello
A
,
Cuadrado-Godia
E
,
Jiménez-Conde
J
,
Pont-Sunyer
C
, et al
Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke
.
Stroke
.
2008
;
39
(
6
):
1717
21
. .
25.
Purroy
F
,
Montaner
J
,
Molina
CA
,
Delgado
P
,
Ribo
M
,
Alvarez-Sabín
J
.
Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes
.
Stroke
.
2007
;
38
(
12
):
3225
9
. .
26.
Leone
MA
,
Capponi
A
,
Varrasi
C
,
Tarletti
R
,
Monaco
F
.
Accuracy of the ICD-9 codes for identifying TIA and stroke in an Italian automated database
.
Neurol Sci
.
2004
;
25
(
5
):
281
8
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.